New treatments for tics?

Neurology

Volumn 56, Issue 5, 2001, Pages 580-581

  Kurlan, Roger ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BACLOFEN; BOTULINUM TOXIN; CLONAZEPAM; CLONIDINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUPHENAZINE; GUANFACINE; HALOPERIDOL; OLANZAPINE; PIMOZIDE; RISPERIDONE; TETRABENAZINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DYSTONIA; EDITORIAL; EXTRAPYRAMIDAL SYMPTOM; GABAERGIC TRANSMISSION; GILLES DE LA TOURETTE SYNDROME; HUMAN; INCIDENCE; IRRITABILITY; MUSCLE WEAKNESS; PARKINSONISM; PHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TIC; VERTIGO; WEIGHT GAIN;

EID: 0035852959     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.5.580     Document Type: Editorial

References (10)

1. The prevalence of Tourette syndrome in a mainstream school population
2. Treatment of ADHD in children with Tourette's syndrome (TACT Trial)
3. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder in Tourette's syndrome: Preliminary clinical experience
4. Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report
5. Risperidone as a treatment for Tourette's syndrome
6. Effective open-label treatment of Tourette's disorder with olanzapine
7. Baclofen treatment in Tourette syndrome: A double-blind, placebocontrolled, crossover trial
8. Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial
9. Rating tic severity
10. Botulinum toxin in the treatment of dystonic tics